Assessment and management of hypertension in patients on dialysis

Journal of the American Society of Nephrology

Volumn 25, Issue 8, 2014, Pages 1630-1646

  Agarwal, Rajiv ^a   Flynn, Joseph ^b   Pogue, Velvie ^c   Rahman, Mahboob ^d   Reisin, Efrain ^e   Weir, Matthew R ^f  

^a INDIANA UNIVERSITY   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

^d UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^e LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^f UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ATENOLOL; CANDESARTAN; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ERYTHROPOIETIN; FOSINOPRIL; LISINOPRIL; LOOP DIURETIC AGENT;

ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE MEASUREMENT; BODY COMPOSITION ANALYZER; DRY WEIGHT; END STAGE RENAL DISEASE; HEMODIALYSIS PATIENT; HUMAN; HYDRATION; HYPERTENSION; HYPOXEMIA; OTOTOXICITY; PERITONEAL DIALYSIS; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; REVIEW; SODIUM RESTRICTION; TREATMENT DURATION; ADULT; AGE; CHILD; COMPLICATION; KIDNEY FAILURE, CHRONIC; MORTALITY;

ADULT; AGE FACTORS; ANTIHYPERTENSIVE AGENTS; CHILD; HUMANS; HYPERTENSION; KIDNEY FAILURE, CHRONIC; RENAL DIALYSIS;

EID: 84909582694     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2013060601     Document Type: Review

References (193)

1. Agarwal R, Nissenson AR, Batlle D, Coyne DW, Trout JR, Warnock DG: Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States. Am J Med 115: 291-297, 2003
2. Salem MM: Hypertension in the hemodialysis population: A survey of 649 patients. Am J Kidney Dis 26: 461-468, 1995
3. Rocco MV, Yan G, Heyka RJ, Benz R, Cheung AK; HEMO Study Group: Risk factors for hypertension in chronic hemodialysis patients: Baseline data from the HEMO study. Am J Nephrol 21: 280-288, 2001
4. Raine AE, Margreiter R, Brunner FP, Ehrich JH, GeerlingsW, Landais P, Loirat C,Mallick NP, Selwood NH, Tufveson G: Report on management of renal failure in Europe, XXII, 1991. Nephrol Dial Transplant 7[Suppl 2]: 7-35, 1992
5. Rahman M, Fu P, Sehgal AR, Smith MC: Interdialytic weight gain, compliance with dialysis regimen, and age are independent predictors of blood pressure in hemodialysis patients. Am J Kidney Dis 35: 257-265, 2000
6. Chavers BM, SolidCA, Daniels FX, Chen SC, Collins AJ, Frankenfield DL, Herzog CA: Hypertension in pediatric long-term hemodialysis patients in the United States. Clin J Am Soc Nephrol 4: 1363-1369, 2009
7. Grekas D, Bamichas G, Bacharaki D, Goutzaridis N, Kasimatis E, Tourkantonis A: Hypertension in chronic hemodialysis patients: Current view on pathophysiology and treatment. Clin Nephrol 53: 164-168, 2000
8. Agarwal R: Epidemiology of interdialytic ambulatory hypertension and the role of volume excess. Am J Nephrol 34: 381-390, 2011
9. Boudville NC, Cordy P,Millman K, Fairbairn L, Sharma A, Lindsay R, Blake PG: Blood pressure, volume, and sodium control in an automated peritoneal dialysis population. Perit Dial Int 27: 537-543, 2007
10. Velasquez MT, Lew SQ, von Albertini B, Mishkin GJ, Bosch JP: Control of hypertension is better during hemodialysis than during continuous ambulatory peritoneal dialysis in ESRD patients. Clin Nephrol 48: 341-345, 1997
11. RoccoMV, FlaniganMJ, Beaver S, Frederick P, Gentile DE, McClellan WM, Polder J, Prowant BF, Taylor L, Helgerson SD; Report fromthe 1995 Core Indicators for Peritoneal Dialysis Study Group: Report from the 1995 Core Indicators for Peritoneal Dialysis Study Group. Am J Kidney Dis 30: 165-173, 1997
12. Cocchi R, Degli Esposti E, Fabbri A, Lucatello A, Sturani A, Quarello F, Boero R, BrunoM, Dadone C, Favazza A, Scanziani R, Tommasi A, Giangrande A: Prevalence of hypertension in patients on peritoneal dialysis: Results of an Italian multicentre study. Nephrol Dial Transplant 14: 1536-1540, 1999
13. Weiler EWJ, Saldanha LF, Khalil-Manesh F, Prins BA, Purdy RE,GonickHC: Relationship of Na-K-ATPase inhibitors to blood-pressure regulation in continuous ambulatory peritoneal dialysis and hemodialysis. J Am Soc Nephrol 7: 454-463, 1996
14. Tonbul Z, Altintepe L, Sözlü C, Yeksan M, Yildiz A, Türk S: Ambulatory blood pressure monitoring in haemodialysis and continuous ambulatory peritoneal dialysis (CAPD) patients. J Hum Hypertens 16: 585-589, 2002
15. Udayaraj UP, Steenkamp R, Caskey FJ, Rogers C, Nitsch D, Ansell D, Tomson CR: Blood pressure and mortality risk on peritoneal dialysis. Am J Kidney Dis 53: 70-78, 2009
16. Konings CJ, Kooman JP, Schonck M, Dammers R, Cheriex E, Palmans Meulemans AP, Hoeks AP, van Kreel B, Gladziwa U, van der Sande FM, Leunissen KM: Fluid status, blood pressure, and cardiovascular abnormalities in patients on peritoneal dialysis. Perit Dial Int 22: 477-487, 2002
17. Tonbul Z, Altintepe L, Sözlü C, Yeksan M, Yildiz A, Türk S: The association of peritoneal transport properties with 24-hour blood pressure levels in CAPD patients. Perit Dial Int 23: 46-52, 2003
18. Wang MC, Tseng CC, Tsai WC, Huang JJ: Blood pressure and left ventricular hypertrophy in patients on different peritoneal dialysis regimens. Perit Dial Int 21: 36-42, 2001
19. Cannella G, Paoletti E, Ravera G, Cassottana P, Araghi P, Mulas D, Peloso G, Delfino R, Messa P: Inadequate diagnosis and therapy of arterial hypertension as causes of left ventricular hypertrophy in uremic dialysis patients. Kidney Int 58: 260-268, 2000
20. Cheigh JS, Milite C, Sullivan JF, Rubin AL, Stenzel KH: Hypertension is not adequately controlled in hemodialysis patients. Am J Kidney Dis 19: 453-459, 1992
21. Bishu K, Gricz KM, Chewaka S, Agarwal R: Appropriateness of antihypertensive drug therapy in hemodialysis patients. Clin J Am Soc Nephrol 1: 820-824, 2006
22. Ertürk S, Ertug AE, Atesx K, Duman N, Aslan SM, Nergisoglu G, Diker E, Erol C, Karatan O, Erbay B: Relationship of ambulatory blood pressure monitoring data to echocardiographic findings in haemodialysis patients. Nephrol Dial Transplant 11: 2050-2054, 1996
23. Lazar AE, Smith MC, Rahman M: Blood pressure measurement in hemodialysis patients. Semin Dial 17: 250-254, 2004
24. Rahman M, Griffin V, Kumar A, Manzoor F, Wright JT Jr, Smith MC: A comparison of standardized versus "usual" blood pressure measurements in hemodialysis patients. AmJ Kidney Dis 39: 1226-1230, 2002
25. Inrig JK, Patel UD, Gillespie BS, Hasselblad V, Himmelfarb J, Reddan D, Lindsay RM, Winchester JF, Stivelman J, Toto R, Szczech LA: Relationship between interdialytic weight gain and blood pressure among prevalent hemodialysis patients. Am J Kidney Dis 50: 108-118, 2007
26. Agarwal R: Volume-associated ambulatory blood pressure patterns in hemodialysis patients. Hypertension 54: 241-247, 2009
27. Thompson AM, Pickering TG: The role of ambulatory blood pressure monitoring in chronic and end-stage renal disease. Kidney Int 70: 1000-1007, 2006
28. Santos SF, Mendes RB, Santos CA, Dorigo D, Peixoto AJ: Profile of interdialytic blood pressure in hemodialysis patients. Am J Nephrol 23: 96-105, 2003
29. Mendes RB, Santos SF, Dorigo D, Mansoor GA, Crowley ST,WhiteWB, Peixoto AJ: The use of peridialysis blood pressure and intradialytic blood pressure changes in the prediction of interdialytic blood pressure in haemodialysis patients. Blood Press Monit 8: 243-248, 2003
30. Rohrscheib MR, Myers OB, Servilla KS, Adams CD, Miskulin D, Bedrick EJ, Hunt WC, Lindsey DE, Gabaldon D, Zager PG; DCI Medical Directors: Age-related blood pressure patterns and blood pressure variability among hemodialysis patients. Clin J Am Soc Nephrol 3: 1407-1414, 2008
31. Argilés A, Mourad G, Mion C: Seasonal changes in blood pressure in patients with end-stage renal disease treated with hemodialysis. N Engl JMed 339: 1364-1370, 1998
32. Conion PJ, Walshe JJ, Heinle SK, Minda S, Krucoff M, Schwab SJ: Predialysis systolic blood pressure correlates strongly withmean 24-hour systolic blood pressure and left ventricularmass in stable hemodialysis patients. J Am Soc Nephrol 7: 2658-2663, 1996
33. Agarwal R, Peixoto AJ, Santos SF, Zoccali C: Pre- and postdialysis blood pressures are imprecise estimates of interdialytic ambulatory blood pressure. Clin J Am Soc Nephrol 1: 389-398, 2006
34. K/DOQI Workgroup: K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis 45[Suppl 3]: S1-S153, 2005
35. Davenport A, Cox C, Thuraisingham R: Achieving blood pressure targets during dialysis improves control but increases intradialytic hypotension. Kidney Int 73: 759-764, 2008
36. Ifudu O, Dawood M, Homel P, Friedman EA: Excess interdialytic weight gain provokes antihypertensive drug therapy in patients on maintenance hemodialysis. Dial Transplant 26: 541, 1997
37. Iseki K, Nakai S, Shinzato T, Morita O, Shinoda T, Kikuchi K, Wada A, Kimata N, Akiba T: Prevalence and determinants of hypertension in chronic hemodialysis patients in Japan. Ther Apher Dial 11: 183-188, 2007
38. López-Gómez JM, Villaverde M, Jofre R, Rodriguez-Benítez P, Pérez-García R: Interdialytic weight gain as a marker of blood pressure, nutrition, and survival in hemodialysis patients. Kidney Int Suppl 93: S63-S68, 2005
39. Rahman M, Dixit A, Donley V, Gupta S, Hanslik T, Lacson E, Ogundipe A,Weigel K, Smith MC: Factors associated with inadequate blood pressure control in hypertensive hemodialysis patients. Am J Kidney Dis 33: 498-506, 1999
40. Luik AJ, Gladziwa U, Kooman JP, van Hooff JP, de Leeuw PW, van Bortel LMAB, Leunissen KML: Influence of interdialytic weight gain on blood pressure in hemodialysis patients. Blood Purif 12: 259-266, 1994
41. Chazot C, Charra B, Laurent G, Didier C, Vo Van C, Terrat JC, Calemard E, Vanel T, Ruffet M: Interdialysis blood pressure control by long haemodialysis sessions. Nephrol Dial Transplant 10: 831-837, 1995
42. Agarwal R, Metiku T, Tegegne GG, Light RP, Bunaye Z, Bekele DM, Kelley K: Diagnosing hypertension by intradialytic blood pressure recordings. Clin J Am Soc Nephrol 3: 1364-1372, 2008
43. Agarwal R: Role of home blood pressure monitoring in hemodialysis patients. Am J Kidney Dis 33: 682-687, 1999
44. Agarwal R, Peixoto AJ, Santos SF, Zoccali C: Out-of-office blood pressure monitoring in chronic kidney disease. Blood Press Monit 14: 2-11, 2009
45. Pickering TG, Miller NH, Ogedegbe G, Krakoff LR, Artinian NT, Goff D; American Heart AssociationAmerican Society of HypertensionPreventive Cardiovascular Nurses Association: Call to action on use and reimbursement for home blood pressure monitoring: A joint scientific statement from the American Heart Association, American Society Of Hypertension, and Preventive Cardiovascular Nurses Association. Hypertension 52: 10-29, 2008
46. Parati G, Stergiou GS, Asmar R, Bilo G, de LeeuwP, Imai Y, Kario K, Lurbe E,Manolis A, Mengden T, O'Brien E, Ohkubo T, Padfield P, Palatini P, Pickering T, Redon J, Revera M, Ruilope LM, Shennan A, Staessen JA, Tisler A, Waeber B, Zanchetti A, Mancia G; ESH Working Group on Blood Pressure Monitoring: European Society of Hypertension guidelines for blood pressure monitoring at home: A summary report of the Second International Consensus Conference on Home Blood Pressure Monitoring. J Hypertens 26: 1505-1526, 2008
47. Agarwal R: Managing hypertension using home blood pressure monitoring among haemodialysis patients-a call to action. Nephrol Dial Transplant 25: 1766-1771, 2010
48. Agarwal R, Andersen MJ, Bishu K, Saha C: Home blood pressure monitoring improves the diagnosis of hypertension in hemodialysis patients. Kidney Int 69: 900-906, 2006
49. Agarwal R, Satyan S, Alborzi P, Light RP, Tegegne GG, Mazengia HS, Yigazu PM: Home blood pressure measurements for managing hypertension in hemodialysis patients. Am J Nephrol 30: 126-134, 2009
50. Agarwal R, Brim NJ, Mahenthiran J, AndersenMJ, SahaC:Out-of-hemodialysisunit blood pressure is a superior determinant of left ventricular hypertrophy. Hypertension 47: 62-68, 2006
51. Moriya H, Ohtake T, Kobayashi S: Aortic stiffness, left ventricular hypertrophy and weekly averaged blood pressure (WAB) in patients on haemodialysis. Nephrol Dial Transplant 22: 1198-1204, 2007
52. Moriya H, Oka M, Maesato K, Mano T, Ikee R, Ohtake T, Kobayashi S:Weekly averaged blood pressure is more important than a single-point blood pressure measurement in the risk stratification of dialysis patients. Clin J Am Soc Nephrol 3: 416-422, 2008
53. Amar J, Vernier I, Rossignol E, Bongard V, Arnaud C, Conte JJ, Salvador M, Chamontin B: Nocturnal blood pressure and 24-hour pulse pressure are potent indicators of mortality in hemodialysis patients. Kidney Int 57: 2485-2491, 2000
54. Alborzi P, Patel N, Agarwal R: Home blood pressures are of greater prognostic value than hemodialysis unit recordings. Clin J Am Soc Nephrol 2: 1228-1234, 2007
55. Agarwal R: Hypervolemia is associated with increased mortality among hemodialysis patients. Hypertension 56: 512-517, 2010
56. da Silva GV, de Barros S, Abensur H,Ortega KC, Mion D Jr; Cochrane Renal Group Prospective Trial Register: CRG060800146: Home blood pressure monitoring in blood pressure control among haemodialysis patients: An open randomized clinical trial. Nephrol Dial Transplant 24: 3805-3811, 2009
57. Kauric-Klein Z, Artinian N: Improving blood pressure control in hypertensive hemodialysis patients. CANNT J 17: 24-28, 31-36, quiz 29-30, 37-38, 2007
58. Agarwal R, Light RP: Chronobiology of arterial hypertension in hemodialysis patients: Implications for home blood pressure monitoring. Am J Kidney Dis 54: 693-701, 2009
59. Mitra S, Chandna SM, Farrington K: What is hypertension in chronic haemodialysis? The role of interdialytic blood pressure monitoring. Nephrol Dial Transplant 14: 2915-2921, 1999
60. Agarwal R, AndersenMJ, Light RP: Location not quantity of blood pressure measurements predicts mortality in hemodialysis patients. Am J Nephrol 28: 210-217, 2008
61. Mansoor GA,WhiteWB: Ambulatory blood pressure monitoring is a useful clinical tool in nephrology. Am J Kidney Dis 30: 591-605, 1997
62. Peixoto AJ, Santos SF, Mendes RB, Crowley ST, Maldonado R, Orias M, Mansoor GA, White WB: Reproducibility of ambulatory blood pressure monitoring in hemodialysis patients. Am J Kidney Dis 36: 983-990, 2000
63. Townsend RR, Ford V: Ambulatory blood pressure monitoring: Coming of age in nephrology. J AmSocNephrol 7: 2279-2287, 1996
64. Agarwal R: Blood pressure and mortality among hemodialysis patients. Hypertension 55: 762-768, 2010
65. Peixoto AJ,Gray TA, Crowley ST: Validation of the SpaceLabs 90207 ambulatory blood pressure device for hemodialysis patients. Blood Press Monit 4: 217-221, 1999
66. Agarwal R, Lewis RR: Prediction of hypertension in chronic hemodialysis patients. Kidney Int 60: 1982-1989, 2001
67. Kelley K, Light RP, Agarwal R: Trended cosinor change model for analyzing hemodynamic rhythm patterns in hemodialysis patients. Hypertension 50: 143-150, 2007
68. Agarwal R, Light RP: Arterial stiffness and interdialytic weight gain influence ambulatory blood pressure patterns in hemodialysis patients. Am J Physiol Renal Physiol 294: F303-F308, 2008
69. Ventura JE, Spósito M: Volume sensitivity of blood pressure in end-stage renal disease. Nephrol Dial Transplant 12: 485-491, 1997
70. Inrig JK, Oddone EZ, Hasselblad V, Gillespie B, Patel UD, Reddan D, Toto R, Himmelfarb J, Winchester JF, Stivelman J, Lindsay RM, Szczech LA: Association of intradialytic blood pressure changes with hospitalization and mortality rates in prevalent ESRD patients. Kidney Int 71: 454-461, 2007
71. Inrig JK, Patel UD, Toto RD, Szczech LA: Association of blood pressure increases during hemodialysis with 2-year mortality in incident hemodialysis patients: A secondary analysis of the Dialysis Morbidity and Mortality Wave 2 Study. Am J Kidney Dis 54: 881-890, 2009
72. Inrig JK: Intradialytic hypertension: A lessrecognized cardiovascular complication of hemodialysis. Am J Kidney Dis 55: 580-589, 2010
73. Chou KJ, Lee PT, Chen CL, Chiou CW, Hsu CY, Chung HM, Liu CP, Fang HC: Physiological changes during hemodialysis in patients with intradialysis hypertension. Kidney Int 69: 1833-1838, 2006
74. Agarwal R, Light RP: Intradialytic hypertension is a marker of volume excess. Nephrol Dial Transplant 25: 3355-3361, 2010
75. Van Buren PN, Kim C, Toto R, Inrig JK: Intradialytic hypertension and the association with interdialytic ambulatory blood pressure. Clin J Am Soc Nephrol 6: 1684-1691, 2011
76. CiritM, Akçiçek F, Terzioglu E, Soydasx C, Ok E, Ozbasxli CF, Basxçi A, Mees EJ: 'Paradoxical' rise in blood pressure during ultrafiltration in dialysis patients. Nephrol Dial Transplant 10: 1417-1420, 1995
77. Agarwal R, Alborzi P, Satyan S, Light RP: Dry-weight reduction in hypertensive hemodialysis patients (DRIP): A randomized, controlled trial. Hypertension 53: 500-507, 2009
78. Inrig JK, Van Buren P, KimC, Vongpatanasin W, Povsic TJ, Toto R: Probing the mechanisms of intradialytic hypertension: A pilot study targeting endothelial cell dysfunction. Clin J Am Soc Nephrol 7: 1300-1309, 2012
79. Miller BW, Cress CL, Johnson ME, Nichols DH, Schnitzler MA: Exercise during hemodialysis decreases the use of antihypertensive medications. Am J Kidney Dis 39: 828-833, 2002
80. Kooman JP, van der Sande F, Leunissen K, Locatelli F: Sodium balance in hemodialysis therapy. Semin Dial 16: 351-355, 2003
81. Krautzig S, Janssen U, Koch KM, Granolleras C, Shaldon S: Dietary salt restriction and reduction of dialysate sodium to control hypertension in maintenance haemodialysis patients. Nephrol Dial Transplant 13: 552-553, 1998
82. Tomson CR: Advising dialysis patients to restrict fluid intake without restricting sodium intake is not based on evidence and is a waste of time. Nephrol Dial Transplant 16: 1538-1542, 2001
83. Bibbins-Domingo K, Chertow GM, Coxson PG, Moran A, Lightwood JM, Pletcher MJ, Goldman L: Projected effect of dietary salt reductions on future cardiovascular disease. N Engl J Med 362: 590-599, 2010
84. OzkahyaM, Toz H,Qzerkan F, Duman S,Ok E, Basci A, Mees EJ: Impact of volume control on left ventricular hypertrophy in dialysis patients. J Nephrol 15: 655-660, 2002
85. Ogden DA: A double blind crossover comparison of high and low sodium dialysis. Proc Clin Dial Transplant Forum 8: 157-165, 1978
86. Cybulsky AV,Matni A, Hollomby DJ: Effects of high sodium dialysate during maintenance hemodialysis. Nephron 41: 57-61, 1985
87. Daugirdas JT, Al-Kudsi RR, Ing TS, Norusis MJ: A double-blind evaluation of sodium gradient hemodialysis. Am J Nephrol 5: 163-168, 1985
88. Barré PE, Brunelle G, Gascon-Barré M: A randomized double blind trial of dialysate sodiums of 145 mEq/L, 150mEq/L, and 155 mEq/L. ASAIO Trans 34: 338-341, 1988
89. Munoz Mendoza J, Sun S, Chertow GM, Moran J, Doss S, Schiller B: Dialysate sodium and sodium gradient in maintenance hemodialysis: A neglected sodium restriction approach? Nephrol Dial Transplant 26: 1281-1287, 2011
90. Flanigan M: Dialysate composition and hemodialysis hypertension. Semin Dial 17: 279-283, 2004
91. Santos SF, Peixoto AJ: Revisiting the dialysate sodium prescription as a tool for better blood pressure and interdialytic weight gain management in hemodialysis patients. Clin J Am Soc Nephrol 3: 522-530, 2008
92. de Paula FM, Peixoto AJ, Pinto LV, Dorigo D, Patricio PJ, Santos SF: Clinical consequences of an individualized dialysate sodium prescription in hemodialysis patients. Kidney Int 66: 1232-1238, 2004
93. Manlucu J, Gallo K, Heidenheim PA, Lindsay RM: Lowering postdialysis plasma sodium (conductivity) to increase sodium removal in volume-expanded hemodialysis patients: A pilot study using a biofeedback software system. Am J Kidney Dis 56: 69-76, 2010
94. Sang GL, Kovithavongs C, Ulan R, Kjellstrand CM: Sodium ramping in hemodialysis: A study of beneficial and adverse effects. Am J Kidney Dis 29: 669-677, 1997
95. Song JH, Lee SW, Suh CK, Kim MJ: Timeaveraged concentration of dialysate sodium relates with sodium load and interdialytic weight gain during sodium-profiling hemodialysis. Am J Kidney Dis 40: 291-301, 2002
96. Davies S, Carlsson O, Simonsen O, Johansson AC, Venturoli D, Ledebo I, Wieslander A, Chan C, Rippe B: The effects of low-sodium peritoneal dialysis fluids on blood pressure, thirst and volume status. Nephrol Dial Transplant 24: 1609-1617, 2009
97. Stewart WK, Fleming LW: Blood pressure control during maintenance haemodialysis with isonatric (high sodium) dialysate. Postgrad Med J 50: 260-264, 1974
98. Sinha AD, Agarwal R: Can chronic volume overload be recognized and prevented in hemodialysis patients? The pitfalls of the clinical examination in assessing volume status. Semin Dial 22: 480-482, 2009
99. Agarwal R, Andersen MJ, Pratt JH: On the importance of pedal edema in hemodialysis patients. Clin J Am Soc Nephrol 3: 153-158, 2008
100. Bridges N, Jarquin-Valdivia AA: Use of the Trendelenburg position as the resuscitation position: To T or not to T?AmJCritCare 14: 364-368, 2005
101. Monnet X, Teboul JL: Passive leg raising. Intensive Care Med 34: 659-663, 2008
102. Vertes V, Cangiano JL, Berman LB, Gould A: Hypertension in end-stage renal disease. N Engl J Med 280: 978-981, 1969
103. Kayikcioglu M, Tumuklu M, Ozkahya M, Ozdogan O, Asci G, Duman S, Toz H, Can LH, Basci A, Ok E: The benefit of salt restriction in the treatment of end-stage renal disease by haemodialysis. Nephrol Dial Transplant 24: 956-962, 2009
104. Goldstein SL, Smith CM, Currier H: Noninvasive interventions to decrease hospitalization and associated costs for pediatric patients receiving hemodialysis. J Am Soc Nephrol 14: 2127-2131, 2003
105. Rodriguez HJ, Domenici R, Diroll A, Goykhman I: Assessment of dry weight by monitoring changes in blood volume during hemodialysis using Crit-Line. Kidney Int 68: 854-861, 2005
106. Patel HP, Goldstein SL, Mahan JD, Smith B, Fried CB, Currier H, Flynn JT: A standard, noninvasive monitoring of hematocrit algorithm improves blood pressure control in pediatric hemodialysis patients. Clin J Am Soc Nephrol 2: 252-257, 2007
107. Reddan DN, Szczech LA, Hasselblad V, Lowrie EG, Lindsay RM, Himmelfarb J, Toto RD, Stivelman J, Winchester JF, Zillman LA, Califf RM, Owen WF Jr: Intradialytic blood volume monitoring in ambulatory hemodialysis patients: A randomized trial.JAmSoc Nephrol 16: 2162-2169, 2005
108. Wizemann V,Wabel P, Chamney P, Zaluska W, Moissl U, Rode C, Malecka-Masalska T, Marcelli D: The mortality risk of overhydration in haemodialysis patients. Nephrol Dial Transplant 24: 1574-1579, 2009
109. Inrig JK, Patel UD, Toto RD, Reddan DN, Himmelfarb J, Lindsay RM, Stivelman J, Winchester JF, Szczech LA: Decreased pulse pressure during hemodialysis is associatedwith improved 6-month outcomes. Kidney Int 76: 1098-1107, 2009
110. Shoji T, Tsubakihara Y, Fujii M, Imai E: Hemodialysis-associated hypotension as an independent risk factor for two-yearmortality in hemodialysis patients. Kidney Int 66: 1212-1220, 2004
111. Tattersall J, Martin-Malo A, Pedrini L, Basci A, Canaud B, FouqueD, Haage P, Konner K, Kooman J, Pizzarelli F, Tordoir J, Vennegoor M, Wanner C, ter Wee P, Vanholder R: EBPG guideline on dialysis strategies. Nephrol Dial Transplant 22 [Suppl 2]: ii5-ii21, 2007
112. Foley RN, Gilbertson DT, Murray T, Collins AJ: Long interdialytic interval and mortality among patients receiving hemodialysis. N Engl J Med 365: 1099-1107, 2011
113. Charra B, Calemard E, Ruffet M, Chazot C, Terrat J-C, Vanel T, LaurentG: Survival as an index of adequacy of dialysis. Kidney Int 41: 1286-1291, 1992
114. Brunet P, Saingra Y, Leonetti F, Vacher-Coponat H, Ramananarivo P, Berland Y: Tolerance of haemodialysis: A randomized cross-over trial of 5-h versus 4-h treatment time. Nephrol Dial Transplant 11[Suppl 8]: 46-51, 1996
115. Chan CT, Floras JS, Miller JA, Richardson RM, Pierratos A: Regression of left ventricular hypertrophy after conversion to nocturnal hemodialysis. Kidney Int 61: 2235-2239, 2002
116. Woods JD, Port FK, Orzol S, Buoncristiani U, Young E,Wolfe RA, Held PJ: Clinical and biochemical correlates of starting "daily" hemodialysis. Kidney Int 55: 2467-2476, 1999
117. Beecroft JM, Hoffstein V, Pierratos A, Chan CT, McFarlane P, Hanly PJ: Nocturnal haemodialysis increases pharyngeal size in patients with sleep apnoea and end-stage renal disease. Nephrol Dial Transplant 23: 673-679, 2008
118. Chan CT, Jain V, Picton P, Pierratos A, Floras JS: Nocturnal hemodialysis increases arterial baroreflex sensitivity and compliance and normalizes blood pressure of hypertensive patients with end-stage renal disease. Kidney Int 68: 338-344, 2005
119. Saad E, Charra B, Raj DS: Hypertension control with daily dialysis. Semin Dial 17: 295-298, 2004
120. Culleton BF, Walsh M, Klarenbach SW, Mortis G, Scott-Douglas N, Quinn RR, TonelliM, Donnelly S, FriedrichMG, Kumar A, Mahallati H, Hemmelgarn BR, Manns BJ: Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: A randomized controlled trial. JAMA 298: 1291-1299, 2007
121. Chertow GM, Levin NW, Beck GJ, Depner TA, Eggers PW, Gassman JJ, Gorodetskaya I, Greene T, James S, Larive B, Lindsay RM, Mehta RL,Miller B, Ornt DB, Rajagopalan S, Rastogi A, Rocco MV, Schiller B, Sergeyeva O, Schulman G, Ting GO, Unruh ML, Star RA, Kliger AS; FHN Trial Group: In-center hemodialysis six times per week versus three times per week. N Engl J Med 363: 2287-2300, 2010
122. Agarwal R: Frequent versus standard hemodialysis. N Engl J Med 364: 975-976, author reply 976, 2011
123. Rocco MV, Lockridge RS Jr, Beck GJ, Eggers PW, Gassman JJ, Greene T, Larive B, Chan CT, Chertow GM, Copland M, Hoy CD, Lindsay RM, Levin NW, Ornt DB, Pierratos A, Pipkin MF, Rajagopalan S, Stokes JB, Unruh ML, Star RA, Kliger AS, Kliger A, Eggers P, Briggs J, Hostetter T, Narva A, Star R, Augustine B, Mohr P, Beck G, Fu Z, Gassman J, Greene T, Daugirdas J, Hunsicker L, Larive B, Li M, Mackrell J, Wiggins K, Sherer S, Weiss B, Rajagopalan S, Sanz J, Dellagrottaglie S, Kariisa M, Tran T, West J, Unruh M, Keene R, Schlarb J, Chan C, McGrath-Chong M, Frome R, HigginsH, Ke S,MandaciO,Owens C, Snell C, Eknoyan G, Appel L, Cheung A, Derse A, Kramer C, Geller N, Grimm R, Henderson L, Prichard S, Roecker E, Rocco M, Miller B, Riley J, Schuessler R, Lockridge R, Pipkin M, Peterson C, Hoy C, Fensterer A, SteigerwaldD, Stokes J, Somers D, Hilkin A, Lilli K, Wallace W, Franzwa B, Waterman E, Chan C, McGrath-Chong M, Copland M, Levin A, Sioson L, Cabezon E, Kwan S, Roger D, Lindsay R, Suri R, Champagne J, Bullas R, Garg A, Mazzorato A, Spanner E, Rocco M, Burkart J, Moossavi S, Mauck V, Kaufman T, Pierratos A, Chan W, Regozo K, Kwok S; Frequent Hemodialysis Network (FHN) Trial Group: The effects of frequent nocturnal home hemodialysis: The Frequent Hemodialysis Network Nocturnal Trial. Kidney Int 80: 1080-1091, 2011
124. Twardowski ZJ: Treatment time and ultrafiltration rate are more important in dialysis prescription than smallmolecule clearance. Blood Purif 25: 90-98, 2007
125. Katzarski KS, Charra B, Luik AJ, Nisell J, Divino Filho JC, Leypoldt JK, Leunissen KM, Laurent G, BergströmJ: Fluid state and blood pressure control in patients treated with long and short haemodialysis. Nephrol Dial Transplant 14: 369-375, 1999
126. Agarwal R, Bouldin JM, Light RP, Garg A: Probing dry-weight improves left ventricular mass index. Am J Nephrol 33: 373-380, 2011
127. Hörl MP, Hörl WH: Drug therapy for hypertension in hemodialysis patients. Semin Dial 17: 288-294, 2004
128. Hayashi SY, Seeberger A, Lind B, Gunnes S, Alvestrand A, do Nascimento MM, Lindholm B, Brodin LA: Acute effects of low and high intravenous doses of furosemide on myocardial function in anuric haemodialysis patients: A tissue Doppler study. Nephrol Dial Transplant 23: 1355-1361, 2008
129. Hoyer J, Schulte KL, Lenz T: Clinical pharmacokinetics of angiotensin converting enzyme (ACE) inhibitors in renal failure. Clin Pharmacokinet 24: 230-254, 1993
130. Agarwal R,WeirMR: Dry-weight: A concept revisited in an effort to avoid medicationdirected approaches for blood pressure control in hemodialysis patients. Clin J Am Soc Nephrol 5: 1255-1260, 2010
131. Zannad F, Kessler M, Lehert P, Grünfeld JP, Thuilliez C, Leizorovicz A, Lechat P: Prevention of cardiovascular events in endstage renal disease: Results of a randomized trial of fosinopril and implications for future studies. Kidney Int 70: 1318-1324, 2006
132. Takahashi A, Takase H, Toriyama T, Sugiura T, Kurita Y, Ueda R, Dohi Y: Candesartan, an angiotensin II type-1 receptor blocker, reduces cardiovascular events in patients on chronic haemodialysis-a randomized study. Nephrol Dial Transplant 21: 2507-2512, 2006
133. Cice G, Ferrara L, D'Andrea A, D'Isa S, Di Benedetto A, Cittadini A, Russo PE, Golino P, Calabrò R: Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathy: A prospective, placebocontrolled trial.JAmColl Cardiol 41: 1438-1444, 2003
134. Heerspink HJ, Ninomiya T, Zoungas S, de Zeeuw D, Grobbee DE, Jardine MJ, Gallagher M, Roberts MA, Cass A, Neal B, Perkovic V: Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: A systematic review and meta-analysis of randomised controlled trials. Lancet 373: 1009-1015, 2009
135. Agarwal R, Sinha AD: Cardiovascular protectionwith antihypertensive drugs in dialysis patients: Systematic review and meta-analysis. Hypertension 53: 860-866, 2009
136. Agarwal R, Sinha AD, PappasMK, Abraham TN, Tegegne GG: Hypertension in hemodialysis treated with atenolol or lisinopril: A randomized controlled trial. Nephrol Dial Transplant 29: 672-681, 2014
137. Buckner FS, Eschbach JW, Haley NR, Davidson RC, Adamson JW: Hypertension following erythropoietin therapy in anemic hemodialysis patients. Am J Hypertens 3: 947-955, 1990
138. Eschbach JW, KellyMR, Haley NR, Abels RI, Adamson JW: Treatment of the anemia of progressive renal failure with recombinant human erythropoietin. N Engl J Med 321: 158-163, 1989
139. Eschbach JW, Abdulhadi MH, Browne JK, Delano BG, Downing MR, Egrie JC, Evans RW, Friedman EA, Graber SE, Haley NR, Korbet S, Krantz SB, Lundin AP, Nissenson AR, Ogden DA, Paganini EP, Rader B, Rutsky EA, Stivelman J, Stone WJ, Teschan P, Van Stone JC, Van Wyck DB, Zuckerman K, Adamson JW: Recombinant human erythropoietin in anemic patients with endstage renal disease. Results of a phase III multicenter clinical trial. Ann Intern Med 111: 992-1000, 1989
140. AbrahamPA,MacresMG: Blood pressure in hemodialysis patients during amelioration of anemia with erythropoietin. J Am Soc Nephrol 2: 927-936, 1991
141. Kaupke CJ, Kim S, Vaziri ND: Effect of erythrocyte mass on arterial blood pressure in dialysis patients receiving maintenance erythropoietin therapy. J Am Soc Nephrol 4: 1874-1878, 1994
142. Lebel M, Kingma I, Grose JH, Langlois S: Hemodynamic and hormonal changes during erythropoietin therapy in hemodialysis patients. JAmSocNephrol 9: 97-104, 1998
143. Wang XQ, Vaziri ND: Erythropoietin depresses nitric oxide synthase expression by human endothelial cells. Hypertension 33: 894-899, 1999
144. Bode-Böger SM, Böger RH, Kuhn M, Radermacher J, Frölich JC: Recombinant human erythropoietin enhances vasoconstrictor tone via endothelin-1 and constrictor prostanoids. Kidney Int 50: 1255-1261, 1996
145. Carlini R, Obialo CI, Rothstein M: Intravenous erythropoietin (rHuEPO) administration increases plasma endothelin and blood pressure in hemodialysis patients. Am J Hypertens 6: 103-107, 1993
146. Carlini RG, Dusso AS, Obialo CI, Alvarez UM, Rothstein M: Recombinant human erythropoietin (rHuEPO) increases endothelin-1 release by endothelial cells. Kidney Int 43: 1010-1014, 1993
147. Eggena P, Willsey P, Jamgotchian N, Truckenbrod L, Hu MS, Barrett JD, Eggena MP, Clegg K, Nakhoul F, Lee DB: Influence of recombinant human erythropoietin on blood pressure and tissue renin-angiotensin systems. Am J Physiol 261: E642-E646, 1991
148. Hand MF, Haynes WG, Johnstone HA, Anderton JL, Webb DJ: Erythropoietin enhances vascular responsiveness to norepinephrine in renal failure. Kidney Int 48: 806-813, 1995
149. Amar J, Vernier I, Rossignol E, Lenfant V, Conte JJ, Chamontin B: Influence of nycthemeral blood pressure pattern in treated hypertensive patients on hemodialysis. Kidney Int 51: 1863-1866, 1997
150. Canadian Erythropoietin Study Group: Effect of recombinant human erythropoietin therapy on blood pressure in hemodialysis patients. Am J Nephrol 11: 23-26, 1991
151. Lebel M, Kingma I, Grose JH, Langlois S: Effect of recombinant human erythropoietin therapy on ambulatory blood pressure in normotensive and in untreated borderline hypertensive hemodialysis patients. Am J Hypertens 8: 545-551, 1995
152. Ishimitsu T, Tsukada H, Ogawa Y, Numabe A, Yagi S: Genetic predisposition to hypertension facilitates blood pressure elevation in hemodialysis patients treated with erythropoietin. Am J Med 94: 401-406, 1993
153. Zoccali C, Benedetto FA, Tripepi G, Cambareri F, Panuccio V, Candela V, Mallamaci F, Enia G, Labate C, Tassone F: Nocturnal hypoxemia, night-day arterial pressure changes and left ventricular geometry in dialysis patients. Kidney Int 53: 1078-1084, 1998
154. Unruh ML, Sanders MH, Redline S, Piraino BM, Umans JG, Hammond TC, Sharief I, Punjabi NM, Newman AB: Sleep apnea in patients on conventional thrice-weekly hemodialysis: Comparison with matched controls from the Sleep Heart Health Study. J Am Soc Nephrol 17: 3503-3509, 2006
155. Abdel-Kader K, Dohar S, Shah N, Jhamb M, Reis SE, Strollo P, Buysse D, Unruh ML: Resistant hypertension and obstructive sleep apnea in the setting of kidney disease. J Hypertens 30: 960-966, 2012
156. Park J, Campese VM: Resistant hypertension and obstructive sleep apnea in end-stage renal disease. J Hypertens 30: 880-881, 2012
157. Tada T, Kusano KF, Ogawa A, Iwasaki J, Sakuragi S, Kusano I, Takatsu S,MiyazakiM, Ohe T: The predictors of central and obstructive sleep apnoea in haemodialysis patients.NephrolDial Transplant 22: 1190-1197, 2007
158. Dorhout Mees EJ: Hypertension in haemodialysis patients: Who cares? Nephrol Dial Transplant 14: 28-30, 1999
159. Duranti E, Imperiali P, Sasdelli M: Is hypertension a mortality risk factor in dialysis? Kidney Int Suppl 55: S173-S174, 1996
160. Fleischmann EH, Bower JD, Salahudeen AK: Are conventional cardiovascular risk factors predictive of two-year mortality in hemodialysis patients? Clin Nephrol 56: 221-230, 2001
161. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE: Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease. Kidney Int 49: 1379-1385, 1996
162. Kalantar-Zadeh K, Kilpatrick RD, McAllister CJ, Greenland S, Kopple JD: Reverse epidemiology of hypertension and cardiovascular death in hemodialysis patients: The 58th annual fall conference and scientific sessions.. Hypertension 45: 811-817, 2005
163. Mazzuchi N, Carbonell E, Fernández-Cean J: Importance of blood pressure control in hemodialysis patient survival. Kidney Int 58: 2147-2154, 2000
164. Salem MM, Bower J: Hypertension in the hemodialysis population: Any relation to one-year survival?AmJ KidneyDis 28: 737-740, 1996
165. Kawamura M, Fijimoto S, Hisanaga S, Yamamoto Y, Eto T: Incidence, outcome, and risk factors of cerebrovascular events in patients undergoing maintenance hemodialysis. AmJ KidneyDis 31: 991-996, 1998
166. van der Sande FM, HermansMM, Leunissen KM, Kooman JP:Noncardiac consequences of hypertension in hemodialysis patients. Semin Dial 17: 304-306, 2004
167. Savazzi GM, Cusmano F, Bergamaschi E, Vinci S, Allegri L, Garini G: Hypertension as an etiopathological factor in the development of cerebral atrophy in hemodialyzed patients. Nephron 81: 17-24, 1999
168. Takeda A, Toda T, Fujii T, Shinohara S, Sasaki S, Matsui N: Discordance of influence of hypertension on mortality and cardiovascular risk in hemodialysis patients. Am J Kidney Dis 45: 112-118, 2005
169. De Lima JJ, LopesHF,Grupi CJ, Abensur H, Giorgi MC, Krieger EM, Pileggi F: Blood pressure influences the occurrence of complex ventricular arrhythmia in hemodialysis patients. Hypertension 26: 1200-1203, 1995
170. Tomita J, Kimura G, Inoue T, Inenaga T, Sanai T, Kawano Y, Nakamura S, Baba S, Matsuoka H,Omae T: Role of systolic blood pressure in determining prognosis of hemodialyzed patients. Am J Kidney Dis 25: 405-412, 1995
171. Port FK, Hulbert-Shearon TE, Wolfe RA, Bloembergen WE, Golper TA, Agodoa LY, Young EW: Predialysis blood pressure and mortality risk in a national sample of maintenance hemodialysis patients. Am J Kidney Dis 33: 507-517, 1999
172. Salem MM: Hypertension in the haemodialysis population: Any relationship to 2-years survival? Nephrol Dial Transplant 14: 125-128, 1999
173. Zager PG, Nikolic J, Brown RH, Campbell MA, Hunt WC, Peterson D, Van Stone J, Levey A, Meyer KB, Klag MJ, Johnson HK, Clark E, Sadler JH, Teredesai P: "U" curve association of blood pressure and mortality in hemodialysis patients. Medical Directors of Dialysis Clinic, Inc. Kidney Int 54: 561-569, 1998
174. Lacson E Jr, Lazarus JM: The association between blood pressure and mortality in ESRD-not different from the general population? Semin Dial 20: 510-517, 2007
175. Li Z, Lacson E Jr, Lowrie EG, Ofsthun NJ, Kuhlmann MK, Lazarus JM, Levin NW: The epidemiology of systolic blood pressure and death risk in hemodialysis patients. Am J Kidney Dis 48: 606-615, 2006
176. Charra B: Control of blood pressure in long slow hemodialysis. Blood Purif 12: 252-258, 1994
177. Stidley CA, HuntWC, Tentori F, Schmidt D, Rohrscheib M, Paine S, Bedrick EJ, Meyer KB, Johnson HK, Zager PG; Medical Directors of Dialysis Clinic Inc: Changing relationship of blood pressure with mortality over time among hemodialysis patients. J Am Soc Nephrol 17: 513-520, 2006
178. Degoulet P, Legrain M, Réach I, Aimé F, Devriés C, Rojas P, Jacobs C: Mortality risk factors in patients treated by chronic hemodialysis. Report of the Diaphane collaborative study. Nephron 31: 103-110, 1982
179. Groothoff J, Gruppen M, de Groot E, Offringa M: Cardiovascular disease as a late complication of end-stage renal disease in children. Perit Dial Int 25[Suppl 3]: S123-S126, 2005
180. Parekh RS, Carroll CE, Wolfe RA, Port FK: Cardiovascular mortality in children and young adults with end-stage kidney disease. J Pediatr 141: 191-197, 2002
181. Mitsnefes M, Stablein D: Hypertension in pediatric patients on long-term dialysis: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS).AmJ Kidney Dis 45: 309-315, 2005
182. Halbach SM, Martz K, Mattoo T, Flynn J: Predictors of blood pressure and its control in pediatric patients receiving dialysis. J Pediatr 160: 621-625, e1, 2012
183. Kramer AM, van Stralen KJ, Jager KJ, Schaefer F, Verrina E, Seeman T, Lewis MA, Boehm M, Simonetti GD, Novljan G, Groothoff JW: Demographics of blood pressure and hypertension in children on renal replacement therapy in Europe. Kidney Int 80: 1092-1098, 2011
184. Mitsnefes MM, Daniels SR, Schwartz SM, Khoury P, Strife CF: Changes in left ventricular mass in children and adolescents during chronic dialysis. Pediatr Nephrol 16: 318-323, 2001
185. Bakkaloglu SA, Borzych D, Soo Ha I, Serdaroglu E, Büscher R, Salas P, Patel H, Drozdz D, Vondrak K, Watanabe A, Villagra J, Yavascan O, Valenzuela M, Gipson D, Ng KH, WaradyBA, Schaefer F; International Pediatric Peritoneal Dialysis Network: Cardiacgeometry in children receiving chronic peritoneal dialysis: Findings from the International Pediatric Peritoneal Dialysis Network (IPPN) registry. Clin J Am Soc Nephrol 6: 1926-1933, 2011
186. Mitsnefes MM, Daniels SR, Schwartz SM, Meyer RA, Khoury P, Strife CF: Severe left ventricular hypertrophy in pediatric dialysis: Prevalence and predictors. Pediatr Nephrol 14: 898-902, 2000
187. Hölttä T, Happonen JM, Rönnholm K, Fyhrquist F, Holmberg C: Hypertension, cardiac state, and the role of volume overload during peritoneal dialysis. Pediatr Nephrol 16: 324-331, 2001
188. Schärer K, Schmidt KG, Soergel M: Cardiac function and structure in patients with chronic renal failure. Pediatr Nephrol 13: 951-965, 1999
189. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents: The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114 [Suppl 4th Report]: 555-576, 2004
190. Kidney Disease Outcomes Quality Initiative (K/DOQI): K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis 43[Suppl 1]: S1-S290, 2004
191. Ulinski T, Genty J, Viau C, Tillous-Borde I, Deschênes G: Reduction of left ventricular hypertrophy in children undergoing hemodialysis. Pediatr Nephrol 21: 1171-1178, 2006
192. Thalange NK, Foster PJ, Gill MS, Price DA, Clayton PE: Model of normal prepubertal growth. Arch Dis Child 75: 427-431, 1996
193. Paglialonga F, Ardissino G, Galli MA, Scarfia RV, Testa S, Edefonti A: Bioimpedance analysis and cardiovascular status in pediatric patients on chronic hemodialysis. Hemodial Int 16[Suppl 1]: S20-S25, 2012